Newsbenzinga
Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug
· Published
Article summary
The FDA approved Takeda's MIMRYLO to treat erythrocytosis in adults with polycythemia vera, offering an effective new hematocrit control.
An excerpt from the original article.
Comments —
Loading comments…